Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LARK DISTILLING CO. LTD Capital/Financing Update 2005

Oct 31, 2005

65265_rns_2005-10-31_fa54b831-9867-4189-bb18-b77f6f73efc2.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

New issue announcement. application for quotation of additional securities and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 1/7/96. Origin: Appendix 5. Amended 1/7/98, 1/9/99, 1/7/2000, 30/9/2001, 11/3/2002.

Name of entity

MONTEC INTERNATIONAL LIMITED

ABN

62 104 600 544

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

  • $\mathbf{1}$ +Class of +securities issued or to be issued
  • Number of +securities issued or to $\overline{2}$ be issued (if known) or maximum number which may be issued
  • Principal terms of the *securities 3 (eg, if options, exercise price and expiry date; if partly paid *securities, the amount outstanding and due dates for payment; if *convertible securities. the conversion price and dates for conversion)

+ See chapter 19 for defined terms.

  • $\boldsymbol{A}$ Do the 'securities rank equally in all respects from the date of allotment with an existing 'class of quoted *securities? If the additional securities do not rank equally, please state: • the date from which they do • the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment • the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment $\mathcal{S}_{\mathcal{S}}$ Issue price or consideration 6 Purpose of the issue (If issued as consideration for the acquisition of assets, clearly identify those assets) $\overline{\tau}$ Dates of entering *securities into uncertificated holdings or despatch of certificates
  • $\bf 8$ Number and +class of all 'securities quoted on ASX (including the securities in clause 2 if applicable)
Number *Class

$+$ See chapter 19 for defined terms.

Number * Class
9 Number
class *
and
οf
all
8,400,000 ORDINARY
'securities not quoted on ASX SHARES - ASX
(including the securities in clause ESCROWED
2 if applicable)
13,665,751 OPTION BALANCE
BROUGHT
FORWARD
MOVEMENTS IN
OPTIONS SINCE
LAST 3B (29/06/05):
1,424,000 GRANTED
LAPSED &
(4,312,425) FORFEITED
NIL EXERCISED
BALANCE OF
OPTIONS
(UNLISTED) OVER
UNISSUED
ORDINARY
10,777,326 SHARES

Dividend policy (in the case of a $\boxed{N}$ trust, distribution policy) on the increased capital (interests) $101$

Part 2 - Bonus issue or pro rata issue

11 holder
N/A
approval
security
Is.
required?
$12 \,$ Is the issue renounceable or non- N/A
renounceable?
13 Ratio in which the *securities will $N/A$
be offered
14 Class of securities to which the N/A
offer relates
15 determine
N/A
*Record
date
to
entitlements

$+$ See chapter 19 for defined terms.

16 Will holdings on different registers
(or subregisters) be aggregated for
calculating entitlements?
N/A
17 Policy for deciding entitlements in
relation to fractions
N/A
18 Names of countries in which the
entity has *security holders who
will not be
sent
new
issue
documents
Note: Security holders must be told how their
entitlements are to be dealt with.
Cross reference: rule 7.7.
N/A
19 οfΙ
Closing
date
for
receipt
acceptances or renunciations
N/A
20 Names of any underwriters N/A
21 Amount of any underwriting fee or
commission
N/A
22 Names of any brokers to the issue N/A
23. Fee or commission payable to the
broker to the issue
N/A
24 Amount of any handling
fee
payable to brokers who lodge
acceptances or renunciations on
behalf of *security holders
N/A
25 If the issue is contingent on
"security holders"
approval, the
date of the meeting
N/A
26 Date entitlement and acceptance
form and prospectus or Product
Disclosure Statement will be sent to
persons entitled
N/A
27 If the entity has issued options, and
the terms entitle option holders to
participate on exercise, the date on
which notices will be sent to option
holders
N/A
28 Date rights trading will begin (if
applicable)
N/A

+ See chapter 19 for defined terms.

29 Date rights trading will end (if N/A
applicable)
30 How do "security holders sell their $\parallel N/A$
entitlements in full through a
broker?
31 How do *security holders sell part $N/A$
of their entitlements through a
broker and accept for the balance?

+ See chapter 19 for defined terms.

-32 How do $*$ security holders dispose $N/A$
of their entitlements (except by sale $\vert$
through a broker)?
-33 *Despatch date N/A

Part 3 - Quotation of securities

You need only complete this section if you are applying for quotation of securities

34 Type of securities
(tick one)

$\Box$ Securities described in Part 1 $(a)$

$(b)$ All other securities

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

Entities that have ticked box 34(a)

Additional securities forming a new class of securities

(If the additional securities do not form a new class, go to $43$ )

Tick to indicate you are providing the information or documents

35 If the "securities are "equity securities, the names of the 20 largest holders of the
additional "securities, and the number and percentage of additional "securities held by
those holders
36 If the "securities are "equity securities, a distribution schedule of the additional
*securities setting out the number of holders in the categories
$1 - 1,000$
$1,001 - 5,000$
$5,001 - 10,000$
10.001 - 100.000
$100,001$ and over
37 A copy of any trust deed for the additional "securities
(now go to 43)

$+$ See chapter 19 for defined terms.

Entities that have ticked box 34(b)

38 *quotation is sought Number of securities for which 9,469,650 FULLY PAID ORDINARY
SHARES
39. Class of *securities for which
quotation is sought
FULLY PAID ORDINARY SHARES
40. Do the securities rank equally in all
respects from the date of allotment
with an existing 'class of quoted
securities?
YES
If the additional securities do not
rank equally, please state:
the date from which they do
which they
the the
extent to
participate for the next dividend,
(in-
the
case
оf
a.
trust.
distribution) or interest payment
the extent to which they do not
rank equally, other than in
relation to the next dividend,
distribution or interest payment
41 Reason for request for quotation
now
Example: In the case of restricted securities, end of
restriction period
END OF RESTRICTION PERIOD
(if issued
upon conversion
οÊ
another security, clearly identify that
other security)
42 Number and class of all securities
quoted on ASX (including the
securities in clause 38)
*Class
Number
57,516,002
ORDINARY
SHARES

(now go to $43$ )

+ See chapter 19 for defined terms.

All entities

Fees

$43$ Payment method (tick one)

Electronic payment made Note: Payment may be made electronically if Appendix 3B is given to ASX electronically at the same time.

Periodic payment as agreed with the home branch has been arranged Note: Arrangements can be made for employee incentive schemes that involve frequent issues of securities.

Quotation agreement

  • $\mathbf{I}$ *Quotation of our additional *securities is in ASX's absolute discretion. ASX may quote the *securities on any conditions it decides.
  • $\overline{2}$ We warrant the following to ASX.
  • The issue of the *securities to be quoted complies with the law and is not for $\bullet$ an illegal purpose.
  • There is no reason why those *securities should not be granted *quotation.
  • An offer of the 'securities for sale within 12 months after their issue will not require disclosure under section $707(3)$ or section $1012C(6)$ of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

  • Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any *securities to be quoted and that no-one has any right to return any *securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the *securities be quoted.
  • We warrant that if confirmation is required under section 1017F of the Corporations Act in relation to the *securities to be quoted, it has been provided at the time that we request that the *securities be quoted.
  • If we are a trust, we warrant that no person has the right to return the *securities to be quoted under section 1019B of the Corporations Act at the time that we request that the *securities be quoted.

$+$ See chapter 19 for defined terms.

  • $\overline{3}$ We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.
  • $\overline{4}$ We give ASX the information and documents required by this form. If any information or document not available now, will give it to ASX before +quotation of the *securities begins. We acknowledge that $\overrightarrow{ASX}$ is relying on the information and documents. We warrant that they are (will be) true and complete.
[original signed]
Sign here: ******** Date: - 01/11/05
Company Secretary

N J V Geddes

Print name:

$\frac{1}{2} \frac{1}{2} \frac{1}{2} \frac{1}{2} \frac{1}{2} \frac{1}{2} \frac{1}{2} \frac{1}{2} \frac{1}{2} \frac{1}{2} \frac{1}{2} \frac{1}{2} \frac{1}{2} \frac{1}{2} \frac{1}{2} \frac{1}{2} \frac{1}{2} \frac{1}{2} \frac{1}{2} \frac{1}{2} \frac{1}{2} \frac{1}{2} \frac{1}{2} \frac{1}{2} \frac{1}{2} \frac{1}{2} \frac{1}{2} \frac{1}{2} \frac{1}{2} \frac{1}{2} \frac{1}{2} \frac{$

$+$ See chapter 19 for defined terms.